Total Joint Reconstruction News

DALLAS — In this video, Adolph V. Lombardi Jr., MD, discusses results that showed a significant association between improvements in walking asymmetry with patient-reported changes in quality of life 1 year after total joint arthroplasty.

Researchers at Scripps Health have received a $317,000 grant from the NIH to conduct research and develop a smart implant for total shoulder arthroplasty, according to a press release.

According to published results, patients using glucagon-like peptide-1 receptor agonists who undergo total shoulder arthroplasty may have increased risks for readmission and several postoperative complications vs. controls.

Published results showed patients who underwent reverse shoulder arthroplasty with glenoid and humeral components from different manufacturers had similar 2-year outcomes compared with patients who had implants from the same manufacturer.

According to published results, patients with PTSD may be at an increased risk for postoperative ED visits, periprosthetic joint infections and revision surgery after total knee arthroplasty compared with patients without PTSD.

Maxx Orthopedics Inc. announced it received FDA clearance of a medial congruent insert for its Freedom total knee arthroplasty system, according to a press release.

Zimmer Biomet Holdings Inc. announced it received FDA 510(k) clearance of its Persona solution porous plasma spray femur implant for total knee replacement, according to a company press release.

Inpatient total knee arthroplasty for patients with a high comorbidity burden may not be cost-effective, as published results showed increased procedural costs were not met with increased hospital revenue in this patient population.

DALLAS — Results presented here showed standard liners and constrained liners had similar rates of aseptic failure and dislocation among patients undergoing revision total hip arthroplasty with a custom triflange acetabular component.

Published results showed a single preoperative IV dose of 8 mg of dexamethasone may improve patient outcomes for pain, vomiting, inflammation and mobility after total knee arthroplasty compared with placebo.